share_log

Immuneering Q1 EPS $(0.49) Misses $(0.46) Estimate

Immuneering Q1 EPS $(0.49) Misses $(0.46) Estimate

Immuneering 第一季度每股收益(0.49 美元)未達預期(0.46 美元)
Benzinga ·  05/07 17:02

Immuneering (NASDAQ:IMRX) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.46) by 6.52 percent. This is a 3.92 percent increase over losses of $(0.51) per share from the same period last year.

Immuneering(納斯達克股票代碼:IMRX)公佈的季度虧損爲每股0.49美元,比分析師普遍預期的0.46美元(0.46美元)低6.52個百分點。這比去年同期每股虧損0.51美元(0.51美元)增長了3.92%。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論